Insiders Marker Therapeutics, Inc.

Equities

MRKR

US57055L2060

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
3.87 ^USD	-3.49%		-6.52%	-29.64%

May. 15	Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M	MT
May. 15	Marker Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Marker Therapeutics, Inc. Receives Approval from United States Adopted Name, Council and International Nonproprietary Names Expert Committee for ?Neldaleucel? as Nonproprietary Name for MT-601	Jan. 22	CI
Marker Therapeutics, Inc. Appoints Eliot M. Lurier as Interim Chief Financial Officer	23-07-03	CI
Marker Therapeutics, Inc. Appoints Monic Stuart, M.D., as Chief Medical Officer	23-05-08	CI
Marker Therapeutics, Inc. Announces Management Changes	23-04-28	CI
Marker Therapeutics, Inc. Announces Chief Executive Officer Changes	23-04-28	CI
Marker Therapeutics, Inc. Announces Mythili Koneru, to Resign as Chief Medical Officer, Effective as of April 9, 2023	23-03-16	CI
Marker Therapeutics, Inc. Announces Resignation of Anthony Kim as Chief Financial Officer, Effective September 30, 2022	22-09-27	CI
Marker Therapeutics, Inc. Announces Frederick Wasserman Will Not Stand for Reelection as Director	22-04-06	CI
Marker Therapeutics, Inc. Appoints Katharine Knobil, M.D., to Board of Directors	21-12-09	CI
Insider Trends: Insider Purchase of Marker Therapeutics Stock Prolongs 90-Day Positive Trend	21-03-18	MT
Insider Trends: Insider Purchase of Marker Therapeutics Stock Continues 90-Day Positive Trend	21-03-18	MT
Insider Trends: Marker Therapeutics Insider 90-Day Buying Trend Added to with Purchase	21-03-18	MT
Insider Trends: Insider Purchase Adds to Marker Therapeutics Positive Trend	21-03-18	MT
Insider Trends: 90-Day Buying Trend Extended with Insider Purchase of Marker Therapeutics Stock	21-03-18	MT
Insider Trends: Insider Purchase Adds to Marker Therapeutics Positive Trend	21-03-18	MT
Insider Trends: 90-Day Buying Trend Prolonged with Insider Purchase of Marker Therapeutics Stock	21-03-18	MT
Insider Trends: Insider Purchase Continues Marker Therapeutics Positive Trend	21-03-18	MT
Insider Trends: Insider Purchase Adds to Marker Therapeutics Positive Trend	21-03-18	MT
Insider Trends: Insider Purchase Adds to Marker Therapeutics Positive Trend	21-03-18	MT
Insider Trends: Insider Buying Continued with Purchase of Marker Therapeutics Stock	21-03-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Marker Therapeutics, Inc.

Equities

MRKR

US57055L2060

Insiders

Filters